Financials
Financial year 2025
Worth noting
- Figures corrected afterwards (2022).
Gross margin
€ -71,970
▼ 109% vs 2024
Profit
Healthy€ 239,063
▼ 43% vs 2024
Debts
Low€ 468,085
▲ 34% vs 2024
FRI-PHARMA from Tongeren-Borgloon, company number BE0866926117, closed financial year 2025 with a result of € 239,063 after tax. For that financial year FRI-PHARMA recorded a gross margin of € -71,970 and equity of € 6.3 million. Compared with financial year 2024, the result moved from € 418,362 to € 239,063. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.
What happened at FRI-PHARMA?
What happened at FRI-PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- YWAG Lux S.à.r.l. BO stepped down as director. NBB
- ALFA ADVISORY S.à.r.l. BO stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 239,063 (▼ 43% vs 2024). Source: NBB ↗
- YWAG Lux S.à.r.l. BO became a director. NBB
- ALFA ADVISORY S.à.r.l. BO became a director. NBB
- New establishment in Gembloux. KBO
- New establishment in Tongeren-Borgloon. KBO
- Start of the company according to the CBE. KBO
In short
From € 483,405 profit in 2021 to € 239,063 profit in 2025.
Paid € 709,187 in corporate taxes since 2021.
Best year ever: 2022, with € 5 million profit.
On average € 151,700 of value added per employee in 2024.
A new publication or filing at FRI-PHARMA? We notify you, reason included.
Follow FRI-PHARMANeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Directors
According to the 2025 annual accounts
YWAG Lux S.à.r.l. BO
Managing director · represented by YVES WEERTS
Also active at: Weerts Logistic Park XXXII, LAURA COAL BELGIUM, Weerts Logistic Park XXXI +33 more
since 2024 · until 2030
ALFA ADVISORY S.à.r.l. BO
Managing director · represented by ALAIN MEUNIER
Also active at: Weerts Logistic Park XXXII, LAURA COAL BELGIUM, Weerts Logistic Park XXXI +33 more
since 2024 · until 2030
Establishments
Establishment units
Physical locations of this company
Heersterveldweg 11
3700 Tongeren-Borgloon
Rue Camille Hubert,Isnes 22
5032 Gembloux
Active since 1 April 2010
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 42 companies are registered at this address.
Weerts Logistic Park XXXII same network
€ -44,715 gross margin · 2025
LAURA COAL BELGIUM same network
€ 1.2 million gross margin · 2025
WEERTS SUPPLY CHAIN
€ 67.4 million revenue · 2025
Weerts Logistic Park XXXI same network
€ -308,220 gross margin · 2025
Suites Life
€ 0 revenue · 2025
+37 more
Details
- Company number
- 0866.926.117
- VAT number
- BE 0866.926.117
- Registered office
- Heersterveldweg 11, 3700 Tongeren-Borgloon
- Names & denominations
- FRI-PHARMA · WLP XIII (A)
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 25 August 2004
- Peppol
- Active · Active since 30 Dec 2025
- Activities · NACE
Opslag
Opslag in koelpakhuizen
Overige opslag